Jundishapur Journal of Microbiology

Published by: Kowsar

Effect of Saccharomyces boulardii Extract on SAP2 Gene Expression and Antifungal Susceptibility of Candida albicans

Reza Mohammad Salehi 1 , Mansour Bayat 1 , Parviz Owlia 2 , * , Seyed Latif Mousavi Gargari 3 and Seyed Jamal Hashemi 4
Authors Information
1 Department of Microbiology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2 Molecular Microbiology Research Center (MMRC), Shahed University, Tehran, Iran
3 Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran
4 Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Jundishapur Journal of Microbiology: March 2018, 11 (3); e59891
  • Published Online: February 17, 2018
  • Article Type: Research Article
  • Received: August 26, 2017
  • Revised: December 23, 2017
  • Accepted: January 9, 2018
  • DOI: 10.5812/jjm.59891

To Cite: Mohammad Salehi R, Bayat M, Owlia P, Mousavi Gargari S L, Hashemi S J. Effect of Saccharomyces boulardii Extract on SAP2 Gene Expression and Antifungal Susceptibility of Candida albicans, Jundishapur J Microbiol. 2018 ; 11(3):e59891. doi: 10.5812/jjm.59891.

Abstract
Copyright © 2018, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusion
Acknowledgements
Footnotes
References
  • 1. Molero G, Diez-Orejas R, Navarro-Garcia F, Monteoliva L, Pla J, Gil C, et al. Candida albicans: genetics, dimorphism and pathogenicity. Int Microbiol. 1998;1(2):95-106. [PubMed: 10943347].
  • 2. Vazquez JA. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl). 2010;2:89-101. [PubMed: 22096388].
  • 3. Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D. Antifungal drug resistance in pathogenic fungi. Med Mycol. 1998;36 Suppl 1:119-28. doi: 10.2147/HIV.S6660. [PubMed: 9988500].
  • 4. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119-28. doi: 10.4161/viru.22913. [PubMed: 23302789].
  • 5. Monod M, Borg-von Zepelin M. Secreted proteinases and other virulence mechanisms of Candida albicans. Chem Immunol. 2002;81:114-28. doi: 10.1159/000058865. [PubMed: 12101999].
  • 6. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003;67(3):400-28. table of contents. doi: 10.1128/MMBR.67.3.400-428.2003. [PubMed: 12966142].
  • 7. Naglik J, Albrecht A, Bader O, Hube B. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol. 2004;6(10):915-26. doi: 10.1111/j.1462-5822.2004.00439.x. [PubMed: 15339267].
  • 8. Naglik JR, Moyes D, Makwana J, Kanzaria P, Tsichlaki E, Weindl G, et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology. 2008;154(Pt 11):3266-80. doi: 10.1099/mic.0.2008/022293-0. [PubMed: 18957581].
  • 9. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21(5):583-90. doi: 10.1111/j.1365-2036.2005.02356.x. [PubMed: 15740542].
  • 10. Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun. 2000;68(10):5998-6004. doi: 10.1128/IAI.68.10.5998-6004.2000. [PubMed: 10992512].
  • 11. Buts JP, De Keyser N. Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci. 2006;51(8):1485-92. doi: 10.1007/s10620-005-9016-x. [PubMed: 16838119].
  • 12. Algin C, Sahin A, Kiraz N, Sahinturk V, Ihtiyar E. Effectiveness of bombesin and Saccharomyces boulardii against the translocation of Candida albicans in the digestive tract in immunosuppressed rats. Surg Today. 2005;35(10):869-73. doi: 10.1007/s00595-005-3049-9. [PubMed: 16175469].
  • 13. Jawhara S, Poulain D. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med Mycol. 2007;45(8):691-700. doi: 10.1080/13693780701523013. [PubMed: 17885943].
  • 14. Krasowska A, Murzyn A, Dyjankiewicz A, Lukaszewicz M, Dziadkowiec D. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res. 2009;9(8):1312-21. doi: 10.1111/j.1567-1364.2009.00559.x. [PubMed: 19732158].
  • 15. ClSI . C.a.L.S. Institute , editor. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-;. CLSI 2008a, , in CLSI document M27-A3. CLSI; 2008. p. 6-12.
  • 16. CLSI . C.a.L.S. Institute , editor. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline. 2nd, in CLSI document M44-A2. 2nd ed. USA: CLSI; 2009.
  • 17. Wu T, Wright K, Hurst SF, Morrison CJ. Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole. Antimicrob Agents Chemother. 2000;44(5):1200-8. doi: 10.1128/AAC.44.5.1200-1208.2000. [PubMed: 10770752].
  • 18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8. doi: 10.1006/meth.2001.1262. [PubMed: 11846609].
  • 19. Murzyn A, Krasowska A, Augustyniak D, Majkowska-Skrobek G, Lukaszewicz M, Dziadkowiec D. The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407. FEMS Microbiol Lett. 2010;310(1):17-23. doi: 10.1111/j.1574-6968.2010.02037.x. [PubMed: 20629753].
  • 20. Feng W, Yang J, Pan Y, Xi Z, Qiao Z, Ma Y. The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains. Can J Microbiol. 2016;62(2):173-8. doi: 10.1139/cjm-2015-0457. [PubMed: 26751517].
  • 21. Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Lukaszewicz M. Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One. 2010;5(8). e12050. doi: 10.1371/journal.pone.0012050. [PubMed: 20706577].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments